» Articles » PMID: 34116109

Activation of Ventral Tegmental Area Neurotensin Receptor-1 Neurons Promotes Weight Loss

Overview
Specialties Neurology
Pharmacology
Date 2021 Jun 11
PMID 34116109
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Dopamine (DA) neurons in the ventral tegmental area (VTA) modulate physical activity and feeding behaviors that are disrupted in obesity. Yet, the heterogeneity of VTA DA neurons has hindered determination of which ones might be leveraged to support weight loss. We hypothesized that increased activity in the subset of VTA DA neurons expressing neurotensin receptor-1 (NtsR1) might promote weight loss behaviors. To test this, we used Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) to activate VTA NtsR1 neurons in normal weight and diet-induced obese mice. Acute activation of VTA NtsR1 neurons (24hr) significantly decreased body weight in normal weight and obese mice by reducing food intake and increasing physical activity. Moreover, daily activation of VTA NtsR1 neurons in obese mice sustained weight loss over 7 days. Activating VTA NtsR1 neurons also suppressed how much mice worked to obtain sucrose rewards, even when there was high motivation to consume. However, VTA NtsR1 neural activation was not reinforcing, nor did it invoke liabilities associated with whole-body NtsR1 agonism such as anxiety, vasodepressor response or hypothermia. Activating VTA NtsR1 neurons therefore promotes dual behaviors that support weight loss without causing adverse effects, and is worth further exploration for managing obesity.

Citing Articles

β-arrestin-biased Allosteric Modulator of Neurotensin Receptor 1 Reduces Ethanol Drinking and Responses to Ethanol Administration in Rodents.

Gereau G, Zhou D, Van Voorhies K, Tyler R, Campbell J, Murray J bioRxiv. 2024; .

PMID: 38645173 PMC: 11030371. DOI: 10.1101/2024.04.10.588903.


The Formation and Function of the VTA Dopamine System.

Hou G, Hao M, Duan J, Han M Int J Mol Sci. 2024; 25(7).

PMID: 38612683 PMC: 11011984. DOI: 10.3390/ijms25073875.


NAPE-PLD in the ventral tegmental area regulates reward events, feeding and energy homeostasis.

Castel J, Li G, Onimus O, Leishman E, Cani P, Bradshaw H Mol Psychiatry. 2024; 29(5):1478-1490.

PMID: 38361126 DOI: 10.1038/s41380-024-02427-6.


Neurotensin and Neurotensin Receptors in Stress-related Disorders: Pathophysiology & Novel Drug Targets.

Kyriatzis G, Khrestchatisky M, Ferhat L, Chatzaki E Curr Neuropharmacol. 2023; 22(5):916-934.

PMID: 37534788 PMC: 10845085. DOI: 10.2174/1570159X21666230803101629.


Neuropeptides Modulate Feeding via the Dopamine Reward Pathway.

Jin R, Sun S, Hu Y, Zhang H, Sun X Neurochem Res. 2023; 48(9):2622-2643.

PMID: 37233918 DOI: 10.1007/s11064-023-03954-4.


References
1.
Lutter M, Bahl E, Hannah C, Hofammann D, Acevedo S, Cui H . Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors. PLoS One. 2017; 12(8):e0181556. PMC: 5573281. DOI: 10.1371/journal.pone.0181556. View

2.
Kelley A, Cador M, Stinus L, Le Moal M . Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding. Psychopharmacology (Berl). 1989; 97(2):243-52. DOI: 10.1007/BF00442258. View

3.
Carraway R, Leeman S . The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem. 1973; 248(19):6854-61. View

4.
Scheggi S, De Montis M, Gambarana C . Making Sense of Rodent Models of Anhedonia. Int J Neuropsychopharmacol. 2018; 21(11):1049-1065. PMC: 6209858. DOI: 10.1093/ijnp/pyy083. View

5.
Kurt G, Woodworth H, Fowler S, Bugescu R, Leinninger G . Activation of lateral hypothalamic area neurotensin-expressing neurons promotes drinking. Neuropharmacology. 2018; 154:13-21. PMC: 6433557. DOI: 10.1016/j.neuropharm.2018.09.038. View